TPA production in mice
Executive Summary
Integrated Genetics and NIH announced Oct. 26 the production of the clot-dissolving agent in the milk of mice through the introduction of human and mouse genetic material in the animal. "This is the first published report in which a research team . . . has induced animals to produce a biologically active human therapeutic protein in their milk," the biotech firm said. Researchers plan to further test the potentially economical production method in larger animals such as goats and cows.
You may also be interested in...
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.